Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Palfi S, Gurruchaga JM, Ralph GS, Lepetit H, Lavisse S, Buttery PC, Watts C, Miskin J, Kelleher M, Deeley S, Iwamuro H, Lefaucheur JP, Thiriez C, Fenelon G, Lucas C, Brugières P, Gabriel I, Abhay K, Drouot X, Tani N, Kas A, Ghaleh B, Le Corvoisier P, Dolphin P, Breen DP, Mason S, Guzman NV, Mazarakis ND, Radcliffe PA, Harrop R, Kingsman SM, Rascol O, Naylor S, Barker RA, Hantraye P, Remy P, Cesaro P, Mitrophanous KA. Palfi S, et al. Among authors: iwamuro h. Lancet. 2014 Mar 29;383(9923):1138-46. doi: 10.1016/S0140-6736(13)61939-X. Epub 2014 Jan 10. Lancet. 2014. PMID: 24412048 Clinical Trial.
White matter alterations in Parkinson's disease with levodopa-induced dyskinesia.
Ogawa T, Hatano T, Kamagata K, Andica C, Takeshige-Amano H, Uchida W, Saito Y, Shimo Y, Oyama G, Umemura A, Iwamuro H, Ito M, Hori M, Aoki S, Hattori N. Ogawa T, et al. Among authors: iwamuro h. Parkinsonism Relat Disord. 2021 Sep;90:8-14. doi: 10.1016/j.parkreldis.2021.07.021. Epub 2021 Jul 24. Parkinsonism Relat Disord. 2021. PMID: 34325387 Free article.
Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson's Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS).
Sato K, Aita N, Hokari Y, Kitahara E, Tani M, Izawa N, Hatori K, Nakamura R, Sasaki F, Sekimoto S, Jo T, Oyama G, Hatano T, Shimo Y, Iwamuro H, Umemura A, Hattori N, Fujiwara T. Sato K, et al. Among authors: iwamuro h. Parkinsons Dis. 2019 Aug 4;2019:7104071. doi: 10.1155/2019/7104071. eCollection 2019. Parkinsons Dis. 2019. PMID: 31467660 Free PMC article.
Young age and severity of motor function are risk factors for psychosis after subthalamic nucleus deep brain stimulation for Parkinson's disease.
Ito M, Sasaki F, Katsuta N, Sekimoto S, Jo T, Nakamura R, Nakajima A, Oyama G, Shimo Y, Iwamuro H, Umemura A, Ohnuma T, Hattori N. Ito M, et al. Among authors: iwamuro h. Psychiatry Clin Neurosci. 2020 May;74(5):328-329. doi: 10.1111/pcn.12991. Epub 2020 Feb 27. Psychiatry Clin Neurosci. 2020. PMID: 32057166 Free article. No abstract available.
44 results